Company
ACELYRIN, Inc. (0001962918)
Standardized SEC financial data for ACELYRIN, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001962918 · Pharmaceutical Preparations.
Return on equity
-54.2%
Free cash flow
-$305.2M
Current ratio
18.10×
EPS (diluted)
$-2.50
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| R&D expense | $38.2M | $55.6M | $355.9M | $238.1M |
| SG&A expense | $3.6M | $13.5M | $66.2M | $66.8M |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Cash & equivalents | $7.5M | $102.2M | $267.1M | $721.3M | $448.4M |
| Total current assets | — | — |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Operating cash flow | -$5.0M | -$61.5M | -$169.7M | -$303.9M |
| Capital expenditures | $0 | $0 | $2.3M | $1.2M |
Get 0001962918 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001962918/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001962918/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"